DYT6 in Japan-genetic screening and clinical characteristics of the patients.
Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan; Department of Epidemiology, Research Institute for Radiation Biology & Medicine, Hiroshima University, Hiroshima, Japan; The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan.
Ryosuke
R
Miyamoto
Hidetaka
H
Koizumi
Hiroyuki
H
Morino
Toshitaka
T
Kawarai
Hirofumi
H
Maruyama
Yohei
Y
Mukai
Ai
A
Miyashiro
Wataru
W
Sako
Yuishin
Y
Izumi
Hideshi
H
Kawakami
Ryuji
R
Kaji
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D051017:Apoptosis Regulatory Proteins / Q000235:genetics*; D001905:Botulinum Toxins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004268:DNA-Binding Proteins / Q000235:genetics*; D046690:Deep Brain Stimulation; D004421:Dystonia / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D005260:Female; D005820:Genetic Testing; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins / Q000235:genetics*; D055815:Young Adult
D018726:Anti-Dyskinesia Agents; D051017:Apoptosis Regulatory Proteins; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C474080:THAP1 protein, human; D001905:Botulinum Toxins